|
US2019071401A1
|
|
Process for the preparation of apremilast
|
|
WO2017175233A1
|
|
Process for large scale liquid phase synthesis of carbetocin and its novel intermediates
|
|
WO2017168431A1
|
|
Process for the preparation of salmeterol xinafoate
|
|
WO2016181406A1
|
|
Improved process for the preparation of aripiprazole with reduced particle size
|
|
MX2017002609A
|
|
Improved process for the preparation of lacosamide and its novel intermediate.
|
|
WO2015104721A2
|
|
An improved process for the preparation of tranexamic acid
|
|
EP3092217A2
|
|
A novel process for preparation of indacaterol or its pharmaceutically acceptable salts
|
|
CA2924821A1
|
|
Purification of organic compounds by surfactant mediated preparative hplc
|
|
EP2776388A2
|
|
A novel process for the preparation of (r)-n-benzyl-2 acetamido-3-methoxypropionamide
|
|
US2014073787A1
|
|
Preparation of 3-[2-[4-((6-fluoro-1, 2-benzisoxazol-3-yl)-l-piperidinyl)-6, 7, 8, 9-tetrahydor-9-hydroxy-2-methyl-4H-pyrido[ 1, 2-A]-pyrimidin-4-one(paliperidone) and paliperidone palmitate
|
|
WO2012127505A2
|
|
Improved process for the preparation of ciprofloxacin and its acid addition salts
|
|
WO2012025935A2
|
|
Process for preparing 2-(2-hydroxyphenyl)-benz[1,3]oxazin-4-one and its use for preparing deferasirox
|
|
EP2609120A1
|
|
Improved process for preparation of sugammadex
|
|
EP2640711A2
|
|
Improved process for the preparation of rufinamide
|
